The observations that the vast majority of tumor emboli in Mary-X fall within lymphatic channels were confirmed by companion podoplanin, LYVE1, and Prox1 immunocytochemical studies (Figure 2A–C). This evidence concerns the gene LYVE1 and neoplasm.